{'fraction_non_alphanumeric': 0.024539877300613498, 'fraction_numerical': 0.0, 'mean_word_length': 5.102803738317757, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Multi-center evaluation of a new wound dressing.

Ninety-two wounds were evaluated for at least three dressing changes each. The vast majority of the wounds were lightly exuding Stage II pressure ulcers and skin tears. This evaluation confirmed the hypothesis that the protective, conformable, and elastic properties of Flexzan, combined with its limited absorption capacity, high moisture vapor permeability and easy to use adhesive system, provided a dressing well suited to the management of the non- to lightly exuding wounds included. In addition, it was found to be a "superior" secondary dressing for alginate dressings on highly exuding wounds.